X0202 4 2004-05-17 0 0001060736 SEATTLE GENETICS INC /WA SGEN 0001106607 JP MORGAN PARTNERS BHCA LP J.P. MORGAN PARTNERS 1221 AVENUE OF THE AMERICAS 40TH FLOOR NEW YORK NY 10020 0 0 1 0 0001243235 JPMP MASTER FUND MANAGER L P JP MORGAN PARTNERS LLC 1221 AVENUE OF THE AMERICAS 40TH FLOOR NEW YORK NY 10020 0 0 1 0 0001243236 JPMP CAPITAL CORP C/O J.P. MORGAN PARTNERS, LLC 1221 AVENUE OF THE AMERICAS 40TH FLOOR NEW YORK NY 10020 0 0 1 0 0000019617 J P MORGAN CHASE & CO 270 PARK AVE 39TH FL NEW YORK NY 10017 0 0 1 0 0001162622 JP MORGAN PARTNERS GLOBAL INVESTORS LP 1221 AVENUE OF THE AMERICAS 40TH FLOOR NEW YORK NY 10020 0 0 1 0 0001167095 J P MORGAN PARTNERS GLOBAL INVESTORS A LP 1221 AVENUE OF THE AMERICAS 40TH FLOOR NEW YORK NY 10020 0 0 1 0 0001169890 J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN LP C/O J P MORGAN PARTNERS 1221 AVENUE OF THE AMERICAS 40TH FL NEW YORK NY 10020 0 0 1 0 0001169889 J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN II LP C/O J P MORGAN PARTNERS 1221 AVENUE OF THE AMERICAS 40TH FL NEW YORK NY 10020 0 0 1 0 0001281161 JPMP GLOBAL INVESTORS L P 1221 AVENUE OF THE AMERICAS 40TH FLOOR NEW YORK NY 10021 0 0 1 0 Warrants 6.25 2003-07-08 2011-12-31 Common Stock 640039 640039 D Warrants 6.25 2003-07-08 2011-12-31 Common Stock 101421 101421 I See Footnote Warrants 6.25 2003-07-08 2011-12-31 Common Stock 13826 13826 I See Footnote Warrants 6.25 2003-07-08 2011-12-31 Common Stock 51478 51478 I See Footnote Warrants 6.25 2003-07-08 2011-12-31 Common Stock 5736 5736 I See Footnote Series A Convertible Preferred Stock 2.50 2004-07-08 Common Stock 5120310 5120310 D Series A Convertible Preferred Stock 2.50 2004-07-08 Common Stock 811370 811370 I See Footnote Series A Convertible Preferred Stock 2.50 2004-07-08 Common Stock 110610 110610 I See Footnote Series A Convertible Preferred Stock 2.50 2004-07-08 Common Stock 411820 411820 I See Footnote Series A Convertible Preferred Stock 2.50 2004-07-08 Common Stock 45890 45890 I See Footnote Stock Options (Right to Purchase) 7.26 2004-05-17 4 A 0 10000 0 A 2005-05-16 2014-05-16 Common Stock 10000 10000 I See Footnote The amount shown represents the beneficial ownership of the Issuer's equity securities by J.P. Morgan Partners Global Investors, L.P. The amount shown represents the beneficial ownership of the Issuer's equity securities by J.P. Morgan Partners Global Investors (Cayman), L.P. The amount shown represents the beneficial ownership of the Issuer's equity securities by J.P. Morgan Partners Global Investors A, L.P. The amount shown represents the beneficial ownership of the Issuer's equity securities by J.P. Morgan Partners Global Investors (Cayman) II, L.P. The conversion price of the Series A Convertible Preferred Stock is equal to the initial purchase price divided by $2.50, as adjusted for stock splits, stock dividends, combinations and other similar capitalizations of the Issuer's Common and Preferred Stock. Initially this results in a 1 for 10 conversion ratio. Each share of Series A Convertible Preferred Stock is entitled to 0.93 votes for each share of Common Stock into which such share of Convertible Preferred Stock could then be converted. All outstanding shares of the Issuer's Series A Convertible Preferred Stock are convertible at the holder's option into shares of the Issuer's Common Stock on a 10 to 1 basis any time after July 8, 2004. This right to convert does not expire. These options were granted to Srinivas Akkaraju, a director of the Issuer. Mr. Akkaraju is obligated to transfer any shares issued under the Stock Option to J.P. Morgan Partners (BHCA), L.P. ("JPM BHCA") at the request of JPM BHCA. Damion E. Wicker 2004-05-19